Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2017 2
2018 3
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group. Fisher BA, et al. Lancet. 2024 Aug 10;404(10452):540-553. doi: 10.1016/S0140-6736(24)01211-X. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096929 Clinical Trial.
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landewé R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G, Patekar M, Mpofu S; FUTURE 2 Study Group. McInnes IB, et al. Lancet. 2015 Sep 19;386(9999):1137-46. doi: 10.1016/S0140-6736(15)61134-5. Epub 2015 Jun 28. Lancet. 2015. PMID: 26135703 Free article. Clinical Trial.
[Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial].
Alekseeva LI, Kashevarova NG, Taskina EA, Strebkova EA, Korotkova TA, Sharapova EP, Savushkina NM, Lila AM, Shostak NA, Mazurov VI, Nesterovich II, Dedkova VA, Vasilyuk VB, Egorova NV, Leontyeva MA, Yakupova SP, Vinogradova IB, Sorotskaya VN, Shirokova LY. Alekseeva LI, et al. Among authors: yakupova sp. Ter Arkh. 2024 Jun 3;96(5):500-509. doi: 10.26442/00403660.2024.05.202788. Ter Arkh. 2024. PMID: 38829812 Clinical Trial. Russian.
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy).
Karateev AE, Pogozheva EY, Filatova EA, Amirjanova VN, Lila AM, Antipova OV, Babaeva AR, Volkorezova AV, Davydova AF, Davtyan VG, Zonova EV, Ivanova ON, Kalinina NN, Kiseleva NI, Knyazeva LA, Kulikov AI, Nesmeyanova OB, Mazurov VI, Masneva LV, Menshikova LV, Obuhova IV, Otteva EN, Salnikova TS, Shсhendrygin IN, Yakupova SP. Karateev AE, et al. Among authors: yakupova sp. Ter Arkh. 2018 Jun 20;90(6):65-73. doi: 10.26442/terarkh201890665-73. Ter Arkh. 2018. PMID: 30701907